Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
11 Março 2024 - 6:05PM
Business Wire
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment, drug delivery, and diagnostic solutions to the
pharmaceutical, biotechnology, and life sciences industries,
announced today that it will participate in the KeyBanc Capital
Markets Virtual Life Sciences & MedTech Investor Forum taking
place from Tuesday, March 19, 2024 to Wednesday, March 20,
2024.
The Company will present on Tuesday, March 19, 2024 at 1:30 p.m.
(ET). A live webcast will be available on the Company’s website at
www.stevanatogroup.com under the "Investors" section. A replay of
the webcast will be available for approximately 90 days after the
event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery and diagnostic solutions to the
pharmaceutical, biotechnology and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes and services that address customer needs across the
entire drug life cycle at each of the development, clinical and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients.
For more information, please visit www.stevanatogroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240311378559/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com
Stevanato (NYSE:STVN)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Stevanato (NYSE:STVN)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024